Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes. - Brazg,R.; Xu,L.; Dalla,MC.; Cobelli,C.; Thomas,K.; Stein,PP. (Diabetes Obes Metab, 2007)